Last reviewed · How we verify

NCT03823937

Evaluation of Smell and Taste in Fibromyalgia

Completed Results posted Last updated 11 June 2020
What this trial tests

trial testing Sniffin' Sticks test and Taste strips in Fibromyalgia in 50 participants. Completed in 10 June 2019.

Timeline
2 January 2019
Primary endpoint
2 June 2019
10 June 2019

Quick facts

Lead sponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date2 January 2019
Primary completion2 June 2019
Estimated completion10 June 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Who can join

Adults 18 to 70, any sex, with Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Sniffin' Sticks Test Score Primary · Baseline

total smell test score minimum score: 0 maximum score: 48 Higher scores reflect better smell function.

GroupValue95% CI
Fibromyalgia25.96± 6.50
Control36.40± 4.50
Taste Strips Test Score Primary · Baseline

total taste score minimum score: 0 maximum score: 16 Higher scores indicate better taste function.

GroupValue95% CI
Fibromyalgia9.93± 2.65
Control13.55± 1.76
Quality of Life Score Secondary · Baseline

A EQ-5D-3L is a standardized instrument for measuring generic health status. minimum score: -0.59 maximum score: 1 Higher scores indicate better health status.

GroupValue95% CI
Fibromyalgia0.452± 0.288
Control0.916± 0.109
Anxiety Score Secondary · Baseline

Hamilton anxiety scale: Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.

GroupValue95% CI
Fibromyalgia21.23± 9.22
Control5.45± 4.24
Alexithymia Score Secondary · Baseline

Toronto alexithymia scale minimum score: 20 maximum score: 100 Cut-off scores: ≤50=no alexithymia, 51-60=borderline alexithymia, and ≥61=alexithymia

GroupValue95% CI
Fibromyalgia57.20± 13.12
Control46.80± 11.30
Depression Score Secondary · Baseline

Hamilton depression scale is designed to rate the severity of depression in patients. Although it contains 21 areas, calculate the patient's score on the first 17 answers. Minimum score:0 Maximum score: 53 Higher scores reflect more severe depression.

GroupValue95% CI
Fibromyalgia18.03± 7.75
Control5.70± 5.98

Sponsor's own description

Patients diagnosed with fibromyalgia syndrome according to 2016 ACR criteria and 18-70 years old healthy subjects will be included in the study. Their smell and taste will be assessed with sniffin sticks and taste strips. Besides they will be evaluated for quality of life, anxiety, depression, and alexithymia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03823937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing